Morepen Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹35.71
- Today's High:
- ₹39.14
- Open Price:
- ₹39.14
- 52W Low:
- ₹23.65
- 52W High:
- ₹48.4
- Prev. Close:
- ₹38.84
- Volume:
- 497421
Company Statistics
- Market Cap.:
- ₹12.08 billion
- Book Value:
- 7.31
- Revenue TTM:
- ₹10.38 billion
- Operating Margin TTM:
- 7.67%
- Gross Profit TTM:
- ₹2.95 billion
- Profit Margin:
- 6.59%
- Return on Assets TTM:
- 6.76%
- Return on Equity TTM:
- 23.04%
Company Profile
Morepen Laboratories Limited had its IPO on under the ticker symbol 500288.
The company operates in the Other sector and Other industry. Morepen Laboratories Limited has a staff strength of 0 employees.
Stock update
Shares of Morepen Laboratories Limited opened at ₹39.14 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹35.71 - ₹39.14, and closed at ₹35.98.
This is a -7.36% slip from the previous day's closing price.
A total volume of 497,421 shares were traded at the close of the day’s session.
In the last one week, shares of Morepen Laboratories Limited have slipped by -7.93%.
Morepen Laboratories Limited's Key Ratios
Morepen Laboratories Limited has a market cap of ₹12.08 billion, indicating a price to book ratio of 3.8119 and a price to sales ratio of 1.2407.
In the last 12-months Morepen Laboratories Limited’s revenue was ₹10.38 billion with a gross profit of ₹2.95 billion and an EBITDA of ₹1.06 billion. The EBITDA ratio measures Morepen Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Morepen Laboratories Limited’s operating margin was 7.67% while its return on assets stood at 6.76% with a return of equity of 23.04%.
In Q3, Morepen Laboratories Limited’s quarterly earnings growth was a positive 566.7% while revenue growth was a positive 57.3%.
Morepen Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 18.4539
- PEG
Its diluted EPS in the last 12-months stands at ₹1.52 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Morepen Laboratories Limited’s profitability.
Morepen Laboratories Limited stock is trading at a EV to sales ratio of 1.1891 and a EV to EBITDA ratio of 10.4052. Its price to sales ratio in the trailing 12-months stood at 1.2407.
Morepen Laboratories Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹11.10 billion
- Total Liabilities
- ₹3.21 billion
- Operating Cash Flow
- ₹-465093000.00
- Capital Expenditure
- ₹459.72 million
- Dividend Payout Ratio
- 0%
Morepen Laboratories Limited ended 2024 with ₹11.10 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹11.10 billion while shareholder equity stood at ₹7.53 billion.
Morepen Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹3.21 billion in other current liabilities, 1022271000.00 in common stock, ₹6.51 billion in retained earnings and ₹744.74 million in goodwill. Its cash balance stood at ₹216.66 million and cash and short-term investments were ₹271.79 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹9.34 million.
Morepen Laboratories Limited’s total current assets stands at ₹7.56 billion while long-term investments were ₹0 and short-term investments were ₹55.13 million. Its net receivables were ₹2.63 billion compared to accounts payable of ₹0 and inventory worth ₹2.29 billion.
In 2024, Morepen Laboratories Limited's operating cash flow was ₹-465093000.00 while its capital expenditure stood at ₹459.72 million.
Comparatively, Morepen Laboratories Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹35.98
- 52-Week High
- ₹48.4
- 52-Week Low
- ₹23.65
- Analyst Target Price
- ₹
Morepen Laboratories Limited stock is currently trading at ₹35.98 per share. It touched a 52-week high of ₹48.4 and a 52-week low of ₹48.4. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹34 and 200-day moving average was ₹30.11 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5034% of the company’s stock are held by insiders while 251.4% are held by institutions.
Frequently Asked Questions About Morepen Laboratories Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-diabetic, and anti-hypertensive; and formulations for antibiotics, gastro-intestinal, CNS, ortho and pain, calcium metabolism, respiratory and anti-allergic, and nutraceuticals and vitamins, as well as diabetes and related complications, and cardiology therapy. It also provides blood glucose and pressure monitors, nebulizers, vaporizers, weighing scales, thermometers, pulse oximeters, massagers and heat therapy, hot water bottles, stethoscopes, sphygmomanometers, ultrasonic nebulizers, fetal Doppler, anti-decubitus air mattress, adult diapers, instant dry under mats, and breathable non-woven tapes. In addition, it provides Burnol for burns and cuts; Forever Young that enhances sexual life, stamina, energy, power, and strength; Lemolate Gold for cold relief; Lemolate- Cough Syrup; Fibre-X Sat-Isabgol, a natural laxative product; Fever-X, a fever reducer; Option72, an emergency contraceptive; Dabgel, an antacid; MoreVital+, a dietary supplement; QuickChek, a pregnancy card; Exygra, a sildenafil citrate; facewashes; Itch Beat for itching; and 2 Kool hair oil. Further, the company offers Active Smile, which is Mouthwash; Dr. Morepen Daily, a health supplement; MTP Kit, a contraception pill; VCalci, a calcium tab; Clean & Pure, an intimate hygiene wash; Liv Healthy, a liver tonic; Head-X for headache; Dr. Morepen Aid, an adhesive first aid dressing; Dr. Morepen Buds, an ear cleaning cotton bud; Cold-EX for cold and cough; Paachan-Arishta, an ayurvedic digestive tonic; and adult nasal spray. Additionally, the company is involved in product contract manufacturing and brand sharing businesses. Morepen Laboratories Limited was founded in 1984 and is based in New Delhi, India.